Company Filing History:
Years Active: 2014-2017
Title: The Innovations of Alasdair Macmillan Robertson: A Pioneer in Cell Culture Methodologies
Introduction: Alasdair Macmillan Robertson is a distinguished inventor based in Bournemouth, GB, known for his groundbreaking work in the field of cell culture methodologies. With two patents to his name, Robertson has made significant contributions that enhance the ability to select and identify cell colonies that produce products of interest.
Latest Patents: Alasdair's most notable patents include a "Method of selecting a monoclonal cell colony" and a "Cell detection" method. The first patent outlines a technique where a plurality of cell culture spaces is utilized, each equipped with an assessment surface containing a first binding agent. This innovative process allows for the efficient selection of a monoclonal cell colony that secretes a product of interest, facilitating crucial advances in cellular bioprocessing. His second patent focuses on the identification of a cell or cell colony producing a polypeptide of interest through the use of a marker compound associated with a reference polypeptide, which streamlines the detection and analysis of desired biological materials.
Career Highlights: Alasdair Macmillan Robertson has made his mark at Molecular Devices Corporation, where he has significantly contributed to the company's research and product development. His inventive approaches have provided substantial advancements in cellular analysis technologies, transforming practices within the biotechnology sector.
Collaborations: Throughout his career, Alasdair has worked alongside notable colleagues such as Julian Francis Burke and Kerensa Klottrup. Their collaborative efforts have enriched the research environment at Molecular Devices Corporation, leading to greater innovation and progress in the field.
Conclusion: Alasdair Macmillan Robertson's innovative patents and contributions to the scientific community illustrate his commitment to advancing cell culture methodologies. His work continues to impact the biotechnology industry, empowering researchers to achieve new heights in the identification and selection of key cellular products.